Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Eslicarbazepine
Drug ID BADD_D00811
Description Adjunctive Therapy for Adults with Partial-Onset Seizures
Indications and Usage Not Available
Marketing Status Not Available
ATC Code N03AF04
DrugBank ID DB14575
KEGG ID D09215
MeSH ID C571001
PubChem ID 9881504
TTD Drug ID D04QZD
NDC Product Code Not Available
Synonyms eslicarbazepine | (10S)-10-hydroxy-10,11-dihydro-5H-dibenzo(b,f)azepin-5-carboxamide
Chemical Information
Molecular Formula C15H14N2O2
CAS Registry Number 104746-04-5
SMILES C1C(C2=CC=CC=C2N(C3=CC=CC=C31)C(=O)N)O
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Anaphylactic shock10.01.07.002; 24.06.02.004--Not Available
Angioedema10.01.05.009; 23.04.01.001--Not Available
Asthenia08.01.01.001--Not Available
Ataxia08.01.02.004; 17.02.02.001--
Blood cholesterol increased13.12.01.002--
Constipation07.02.02.001--
Cough22.02.03.001--
Depression19.15.01.001--
Dermatitis23.03.04.002--Not Available
Diarrhoea07.02.01.001--
Diplopia06.02.06.002; 17.17.01.005--Not Available
Dizziness02.01.02.004; 17.02.05.003; 24.06.02.007--
Dysarthria17.02.08.001; 19.19.03.001--
Ear disorder04.03.01.001--Not Available
Eosinophilia01.02.04.001--
Eye disorder06.08.03.001--Not Available
Fatigue08.01.01.002--
Gait disturbance08.01.02.002; 17.02.05.016--
Gastritis07.08.02.001--
Gastrointestinal disorder07.11.01.001--Not Available
Gastrointestinal pain07.01.05.005--
Headache17.14.01.001--
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Hyponatraemia14.05.04.002--
Infection11.01.08.002--Not Available
Insomnia17.15.03.002; 19.02.01.002--
Memory impairment17.03.02.003; 19.20.01.003--
Nausea07.01.07.001--
The 1th Page    1 2    Next   Last    Total 2 Pages